NYMX - farmaco cancro prostata

MI GUSTA...
Southpoint Capital Advisors Lp : SC 13G
2006-03-30 17:29 (New York)

COMPANY: Southpoint Capital Advisors Lp
FORM: SC 13G
LANG: English
-0- Mar/30/2006 22:29 GMT

2,681,140 purchased representing 9.88% of the outstanding shares of NYMX.
:D OK!
 
Rob Butts and Josh Clark, two former Greenlight Capital analysts who left the firm in February, have launched three new funds. The pair's management company, New York-based Southpoint Capital Advisors, launched its funds with $47 million. The funds have a deep value approach and focus on special situations, Clark said. They invest primarily in U.S. equities but also dabble in distressed debt, he added. The firm is currently hunting for a couple of equity analysts, Clark noted. The funds carry a 1.5% management fee, a 20% performance fee and a $1 million minimum. The prime broker is UBS
 
piena consolidamento..:D

occhio al break.. da monitorare intraday oppure da prendere ora, mettere uno stop sotto il supporto e attendere il break.;)
 

Allegati

  • nymx2.png
    nymx2.png
    14,7 KB · Visite: 146
Nymox AlzheimAlert(TM) Findings To Be Presented at National Meeting in Dallas
Tuesday March 14, 1:00 pm ET


HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--March 14, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) is pleased to announce that positive data from successful clinical studies of the Company's AlzheimAlert(TM) test will be presented at the Annual Symposium of the American Medical Directors Association in Dallas this week. Study results will be presented by first author Dr. Ira Goodman of the Orlando Regional Healthcare System. Dr. Goodman was a principal investigator in the reported studies.
ADVERTISEMENT


In addition to data, several specific case histories in the presentation highlight the usefulness of the AlzheimAlert(TM) technology. Dr. Goodman's presentation also includes cases where the AlzheimAlert(TM) accuracy was confirmed by longer clinical followup and by brain biopsy. The abstract is available by request to info@nymox.com

Dr. Goodman is Chairman of the Department of Neurology of the Orlando Regional Healthcare System, and is Director of the Memory Disorder Clinic and Associate Clinical Professor in the Department of Medicine at the University of Florida School of Medicine. Dr Goodman is also Faculty of Florida State University Medical School, and member of the Research Sub-committee of the Alzheimer's Disease Initiative of the Department of Elder Affairs of the State of Florida.

The AlzheimAlert(TM) test is a urine based diagnostic aid for Alzheimer's disease. It is the only proven accurate non-invasive AD test technology available. The test has the CE Mark, allowing it to be marketed in Europe, and is CLIA certified as a laboratory test service which is available in the U.S. Nymox currently has numerous initiatives underway for the AlzheimAlert(TM) testing technology, including marketing and distribution overseas, and global product development.

There are an estimated 4.5 million people with Alzheimer's disease in the United States alone; by 2050 this number is projected to increase almost three times to 13.2 million. Worldwide estimates of the current number of people with Alzheimer's disease range from 15 to 20 million. The annual national direct and indirect costs of caring for Alzheimer patients in the U.S. alone are estimated at $100 billion. The human toll on patients, families and caregivers is incalculable.

More information about Nymox is available at www.nymox.com, email: info@nymox.com, or 800-936-9669.

This press release contains certain "forward-looking statements" as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors are detailed from time to time in Nymox's filings with the United States Securities and Exchange Commission and other regulatory authorities.
 
ei Walter la abbandoni proprio ora ?

+ 44%

Open 3.70
Higt 5.45
Close 5.23

quì deve essere capitato un bel fattaccioOK!
 
5.60!!!

Dio Mio!!!!!!!!!!!


le ho sul TOOL ordinario...non posso fare nulla!! me le ero dimenticate!!!

sono sul TOOL telefonico insieme a EAG:angry: :angry: :angry: :angry:
 
Mr China Investiment ha scritto:
5.60!!!

Dio Mio!!!!!!!!!!!


le ho sul TOOL ordinario...non posso fare nulla!! me le ero dimenticate!!!

sono sul TOOL telefonico insieme a EAG:angry: :angry: :angry: :angry:


vendi tutto OK! OK! OK!

ora ti faccio anche da ragioniere :censored:
 
Mr China Investiment ha scritto:
non posso fare nulla......


domani ..:rolleyes:

il solito fortunato, di questo passo di si aumenta ancora il bel malloppo:D :D :D
 
Indietro